Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $60.01 USD
Change Today -0.34 / -0.56%
Volume 245.9K
AMAG On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

amag pharmaceuticals inc (AMAG) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/23/15 - $60.84
52 Week Low
05/12/14 - $17.18
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

amag pharmaceuticals inc (AMAG) Related Businessweek News

No Related Businessweek News Found

amag pharmaceuticals inc (AMAG) Details

AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company markets Feraheme in the United States and Canada; and as Rienso in the European Union. It sells Feraheme to authorized wholesalers and specialty distributors. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.

257 Employees
Last Reported Date: 02/18/15
Founded in 1981

amag pharmaceuticals inc (AMAG) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $534.6K
President and Chief Operating Officer
Total Annual Compensation: $435.8K
Chief Accounting Officer, Senior Vice Preside...
Total Annual Compensation: $277.9K
Senior Vice President of Legal Affairs, Gener...
Total Annual Compensation: $337.5K
Senior Vice President of Sales & Marketing
Total Annual Compensation: $264.4K
Compensation as of Fiscal Year 2014.

amag pharmaceuticals inc (AMAG) Key Developments

AMAG Pharmaceuticals Seeks Acquisitions

Linda Lennox, Vice President of Investor Relations and Corporate Communications of AMAG Pharmaceuticals, Inc. (NasdaqGS:AMAG) said that the company is planning on transformative and smaller tuck in acquisitions moving forward to further bolster the bottom line and expand, completing an equity offering in March of $200 million to help make further acquisitions.

AMAG Pharmaceuticals, Inc. Proposes Amendment to Certificate of Incorporation

AMAG Pharmaceuticals, Inc. announced that it will propose amendment to certificate of incorporation at the annual meeting of stockholders to be held on May  21, 2015.

Amag Pharmaceuticals, Inc. Promotes Frank E. Thomas to President

On April 1, 2015, the board of directors of AMAG Pharmaceuticals, Inc. promoted Frank E. Thomas to president from executive vice president of the company, effective immediately, reporting to William K. Heiden, chief executive officer. Mr. Thomas joined the company as executive vice president and chief financial officer in August 2011. In November 2011, Mr. Thomas was appointed the company's chief operating officer and executive vice president. From November 2011 to May 2012, he also served as the company's interim president and chief executive officer. Mr. Thomas will continue to serve as the company's chief operating officer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMAG:US $60.01 USD -0.34

AMAG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMAG.
View Industry Companies

Industry Analysis


Industry Average

Valuation AMAG Industry Range
Price/Earnings 11.1x
Price/Sales 11.5x
Price/Book 3.3x
Price/Cash Flow 13.5x
TEV/Sales 9.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMAG PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at